blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3058097

EP3058097 - SENSE-ANTISENSE GENE PAIRS FOR PATIENT STRATIFICATION, PROGNOSIS, AND THERAPEUTIC BIOMARKERS IDENTIFICATION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  25.09.2020
Database last updated on 31.08.2024
FormerGrant of patent is intended
Status updated on  07.01.2020
Most recent event   Tooltip25.09.2020Application deemed to be withdrawnpublished on 28.10.2020  [2020/44]
Applicant(s)For all designated states
Agency for Science, Technology and Research
1 Fusionopolis Way 20-10 Connexis
Singapore 138632 / SG
[2016/34]
Inventor(s)01 / GRINCHUK, Oleg
c/o Bioinformatics Institute
30 Biopolis Street
07-01 Matrix
Singapore 138671 / SG
02 / MOTAKIS, Efthimios
c/o Bioinformatics Institute
30 Biopolis Street
07-01 Matrix
Singapore 138671 / SG
03 / YENAMANDRA, Surya Pavan
c/o Bioinformatics Institute
30 Biopolis Street
07-01 Matrix
Singapore 138671 / SG
04 / KUZNETSOV, Vladimir Andreevich
c/o Bioinformatics Institute
30 Biopolis Street
07-01 Matrix
Singapore 138671 / SG
 [2016/34]
Representative(s)Williams, Andrea
Marks & Clerk LLP
62-68 Hills Road
Cambridge CB2 1LA / GB
[2016/34]
Application number, filing date14853366.420.10.2014
[2016/34]
WO2014SG00492
Priority number, dateSG2013000791718.10.2013         Original published format: SG 201307917
[2016/34]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015057169
Date:23.04.2015
Language:EN
[2015/16]
Type: A1 Application with search report 
No.:EP3058097
Date:24.08.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 23.04.2015 takes the place of the publication of the European patent application.
[2016/34]
Search report(s)International search report - published on:AU23.04.2015
(Supplementary) European search report - dispatched on:EP29.09.2017
ClassificationIPC:G16B40/20, G16B25/10
[2019/46]
CPC:
G16B25/10 (EP,US); C12Q1/6886 (EP,US); G16B20/00 (EP,US);
G16B20/20 (EP,US); G16B25/00 (US); G16B35/00 (EP,US);
G16B40/00 (EP,US); G16B40/20 (EP,US); G16C20/60 (EP,US);
C12Q2600/106 (US); C12Q2600/118 (EP,US); C12Q2600/158 (EP,US) (-)
Former IPC [2017/30]G06F19/18, C12Q1/68
Former IPC [2016/34]C12Q1/68, G06F17/18
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/34]
TitleGerman:SENSE-ANTISENSE-GENPAARE FÜR PATIENTENSCHICHTUNG UND -PROGNOSE SOWIE IDENTIFIKATION THERAPEUTISCHER BIOMARKER[2016/34]
English:SENSE-ANTISENSE GENE PAIRS FOR PATIENT STRATIFICATION, PROGNOSIS, AND THERAPEUTIC BIOMARKERS IDENTIFICATION[2016/34]
French:PAIRES DE GÈNES SENS-ANTISENS POUR LA STRATIFICATION DE PATIENTS, LE PRONOSTIC ET L'IDENTIFICATION DE BIOMARQUEURS THÉRAPEUTIQUES[2016/34]
Entry into regional phase10.05.2016National basic fee paid 
10.05.2016Search fee paid 
10.05.2016Designation fee(s) paid 
10.05.2016Examination fee paid 
Examination procedure14.08.2015Request for preliminary examination filed
International Preliminary Examining Authority: AU
10.05.2016Examination requested  [2016/34]
20.03.2018Amendment by applicant (claims and/or description)
08.01.2020Communication of intention to grant the patent
03.06.2020Application deemed to be withdrawn, date of legal effect  [2020/44]
24.06.2020Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2020/44]
Fees paidRenewal fee
11.10.2016Renewal fee patent year 03
25.10.2017Renewal fee patent year 04
11.10.2018Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.10.201906   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XP]  - Oleg V Grinchuk ET AL, "Sense-antisense gene-pairs in breast cancer and associated pathological pathways", Oncotarget, United States, (20151208), page 42197, URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747219/pdf/oncotarget-06-42197.pdf, (20170612), XP055380726 [XP] 1-5,15 * the whole document *

DOI:   http://dx.doi.org/10.18632/oncotarget.6255
International search[X]WO2010104472  (AGENCY SCIENCE TECH & RES [SG], et al);
 [X]WO2010104474  (AGENCY SCIENCE TECH & RES [SG], et al);
 [X]US8435734  (KIYOSAWA HIDENORI [JP], et al);
 [XL]  - GRINCHUK, O. V. ET AL., "Complex sense-antisense architecture of TNFAIP1/POLDIP2 on 17q11.2 represents a novel transcriptional structural-functional gene module involved in breast cancer progression", BMC GENOMICS, vol. 11, no. 1, (2010), page S9, URL: http://www.biomedcentral.com/content/pdf/1471-2164-11-S1-S9.pdf, (20150106), XP055064273

DOI:   http://dx.doi.org/10.1186/1471-2164-11-S1-S9
 [XL]  - GRINCHUK, O ET AL., "Identification of complex sense-antisense gene 's module on 17q11.2 associated with breast cancer aggressiveness and patient's survival", WORLD ACADEMY OF SCIENCE , ENGINEERING AND TECHNOLOGY, (2009), vol. 58, pages 1046 - 1056, XP009169914
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.